Business Trends

Dec 02, 2014
BioPharm International
By BioPharm International Editors
Japanese drugmaker Otsuka announced plans to buy CNS-specialist Avanir Pharmaceuticals for $3.5 billion in an all-cash tender offer.
Dec 01, 2014
BioPharm International
Biotech drug manufacturers' emails may have been hacked by individuals with sophisticated investment banking skills, according to a report from the New York Times.
Dec 01, 2014
BioPharm International
Biopharma employees report gains in compensation and job satisfaction, as industry growth continues.
Nov 25, 2014
Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.
Nov 25, 2014
By BioPharm International Editors
Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.
Nov 24, 2014
Approximately 40% of total global growth will come from specialty medications, according to a new report from the IMS Institute for Healthcare Informatics.
Nov 15, 2014
BioPharm International
Dual sourcing is one of many possible solutions to securing the supply chain.
Nov 15, 2014
BioPharm International
Biopharma continues to adopt single-use technologies, but also seeks more innovation and improvements in products.
Nov 04, 2014
M&A transactions accounted for nearly $15 billion more this year than for the same period a year ago.
Nov 01, 2014
BioPharm International
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.
native1_300x100
lorem ipsum